Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004625758 | SCV005115653 | uncertain significance | not specified | 2024-06-10 | criteria provided, single submitter | clinical testing | The c.3923G>T (p.R1308L) alteration is located in exon 3 (coding exon 2) of the FLG2 gene. This alteration results from a G to T substitution at nucleotide position 3923, causing the arginine (R) at amino acid position 1308 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |